Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 9/20 | 0.48 |
| ▸ | RECQL | P46063 | 8/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.48 |
| ▸ | MAPT | P10636 | 7/20 | 0.48 |
| ▸ | BLM | P54132 | 5/20 | 0.48 |
| ▸ | LMNA | P02545 | 5/20 | 0.48 |
| ▸ | APEX1 | P27695 | 4/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.48 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.48 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.48 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.48 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.48 |
| ▸ | DRD2 | P14416 | 2/20 | 0.48 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1332823 | 1.00 | TDP1 (0.48) | TDP1RECQLKDM4EMAPTBLM | |
| SCHEMBL13176447 | 0.78 | TDP1 (0.48) | TDP1RECQLKDM4EMAPTBLM | |
| SCHEMBL2506281 | 0.77 | TSHR (0.61) | TDP1BLMKMT2AMEN1HPGD | |
| SCHEMBL30924863 | 0.77 | TSHR (0.61) | TDP1BLMKMT2AMEN1HPGD | |
| Formic Acid SCHEMBL29183960 | 0.77 | TDP1 (0.55) | TDP1RECQLKDM4EMAPTBLM | |
| SCHEMBL15973924 | 0.77 | KDM4E (0.43) | TDP1RECQLKDM4EMAPTBLM | |
| SCHEMBL15688141 | 0.77 | SHBG (0.44) | TDP1RECQLKDM4EMAPTBLM | |
| SCHEMBL20361608 | 0.77 | TDP1 (0.50) | TDP1RECQLKDM4EMAPTBLM | |
| SCHEMBL28165577 | 0.77 | TDP1 (0.50) | TDP1RECQLKDM4EMAPTBLM | |
| SCHEMBL7192542 | 0.77 | TDP1 (0.50) | TDP1RECQLKDM4EMAPTBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116990405-A | Marker for predicting curative effect of ketamine on treating depression, screening method and application thereof | 广州医科大学附属脑科医院 | 2023-11-03 | — | — | CN | claimed |
| US-12582704-B2 | Food composition for improving behavioral and motor function containing aldehyde dehydrogenase for reducing aldehydes produced by oxidation of alcohol | PICOENTECH Co., LTD. (KR) | 2026-03-24 | — | — | US | disclosed |
| EP-4704971-A1 | GAMMA STIMULATION AND NEUROMODULATOR COMBINATION THERAPY | Cognito Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| US-20250360285-A1 | SENSORY GAMMA STIMULATION THERAPY IMPROVES SLEEP QUALITY AND MAINTAINS FUNCTIONAL ABILITY IN ALZHEIMERS DISEASE PATIENTS | COGNITO THERAPEUTICS INC (US) | 2025-11-27 | — | — | US | disclosed |
| EP-4627069-A1 | FOOD AND PHARMACEUTICAL COMPOSITION FOR DETOXIFYING ENDOGENOUS ALDEHYDES | Picoentech Co., Ltd. (KR) | 2025-10-08 | — | — | EP | disclosed |
| EP-4626259-A1 | NOVEL ALDEHYDE DEHYDROGENASE FOOD AND DRUG COMPOSITION FOR IMPROVING BEHAVIOR AND MOTOR FUNCTION | Picoentech Co., Ltd. (KR) | 2025-10-08 | — | — | EP | disclosed |
| US-20250152601-A1 | Compositions and Methods for the Treatment of Sexual Dysfunctions | THE JONATHAN HURT LIVING TRUST (US) | 2025-05-15 | — | — | US | disclosed |
| US-20250154550-A1 | HANGOVER RELIEVER CONTAINING GLUTATHIONE AND ALDEHYDE DEHYDROGENASE | PICO ENTECH CO., LTD. (KR) | 2025-05-15 | — | — | US | disclosed |
| CN-118325814-B | Sophora japonica exosomes and application thereof in preparation of drugs for treating damage to digestive tract mucous membrane barrier | 中国人民解放军总医院第一医学中心 | 2025-04-22 | — | — | CN | disclosed |
| US-20250090642-A1 | FOOD COMPOSITION FOR IMPROVING BEHAVIORAL AND MOTOR FUNCTION CONTAINING ALDEHYDE DEHYDROGENASE FOR REDUCING ALDEHYDES PRODUCED BY OXIDATION OF AMINE | PICOENTECH Co., LTD. (KR) | 2025-03-20 | — | — | US | disclosed |
| US-20230111776-A1 | METHODS OF ENHANCING NEUROSTIMULATION DURING ACTIVITIES | HERCULES CAPITAL, INC. | 2023-04-13 | — | — | US | disclosed |
| US-20230104621-A1 | ENTERTAINMENT DEVICE FOR PROMOTING GAMMA OSCILATIONS | HERCULES CAPITAL, INC. | 2023-04-06 | — | — | US | disclosed |
| WO-2023049470-A1 | METHODS OF ENHANCING NEUROSTIMULATION DURING ACTIVITIES | Cognito Therapeutics, Inc. (US) | 2023-03-30 | — | — | WO | disclosed |
| WO-2023049467-A1 | ENTERTAINMENT DEVICE FOR PROMOTING GAMMA OSCILLATIONS | Cognito Therapeutics, Inc. (US) | 2023-03-30 | — | — | WO | disclosed |
| US-20230051207-A1 | HANGOVER RELIEVER CONTAINING GLUTATHIONE AND ALDEHYDE DEHYDROGENASE | PICO ENTECH CO., LTD. (KR) | 2023-02-16 | — | — | US | disclosed |
| EP-3611159-B1 | DIHYDROXYPHENYL NEUROTRANSMITTER COMPOUNDS, COMPOSITIONS AND METHODS | AUSPEX PHARMACEUTICALS INC (US) | 2023-01-25 | — | — | EP | disclosed |
| CN-115087726-A | Hangover relief agent containing glutathione and aldehyde dehydrogenase | 匹克生物酶高科技有限公司 | 2022-09-20 | — | — | CN | disclosed |
| US-20220229077-A1 | DIAGNOSIS, PROGNOSIS AND TREATMENT FOR SCHIZOPHRENIA AND SCHIZOAFFECTIVE PSYCHOSIS | PRECISION MEDICINE HOLDINGS PTY LTD (AU) | 2022-07-21 | — | — | US | disclosed |
| US-20220072131-A1 | Dihydroxyphenyl Neurotransmitter Compounds, Compositions And Methods | AUSPEX PHARMACEUTICALS INC (US) | 2022-03-10 | — | — | US | disclosed |
| WO-2022027030-A1 | SENSORY GAMMA STIMULATION THERAPY IMPROVES SLEEP QUALITY AND MAINTAINS FUNCTIONAL ABILITY IN ALZHEIMERS DISEASE PATIENTS | Cognito Therapeutics, Inc. (US) | 2022-02-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220072131-A1 | Dihydroxyphenyl Neurotransmitter Compounds, Compositions And Methods | SLC18A2, COMT, SLC6A2 | TDP1 1161/4885RECQL 1726/4885KDM4E 1137/4885 |
| US-12582704-B2 | Food composition for improving behavioral and motor function containing aldehyde dehydrogenase for reducing aldehydes produced by oxidation of alcohol | ADH1C, ADH1A, ALDH2 | TDP1 315/4885RECQL 1194/4885KDM4E 1042/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.